Metformin: The First-Line Drug That Doesn't Cause Hypos
Metformin is the most prescribed diabetes drug in the world, and for good reason: it lowers glucose, is cheap, doesn't cause weight gain, and almost never causes a hypo. It works not by pushing out more insulin but by making the body listen better — starting with the liver. Understanding that one difference explains its greatest strength and its rare but serious danger.
When someone is diagnosed with type 2 diabetes, the first drug reached for, almost everywhere in the world, is metformin. It has held that first-line position for decades because it hits a sweet spot no other drug quite matches: it reliably lowers glucose, costs almost nothing, tends to cause slight weight loss rather than gain, and — crucially — does not by itself cause hypoglycaemia. To see why it's so safe, and where its one real danger lies, you have to understand that it treats type 2 diabetes at its root: not by adding insulin, but by fixing the body's deafness to the insulin it already has.
How it works — and why no hypos
Metformin lowers glucose without forcing insulin out. Metformin's main action is on the liver: it reduces the amount of new glucose the liver makes and releases into the blood (the liver is a surprisingly big source of the high glucose in type 2 diabetes). It also makes muscle and fat more sensitive to insulin, so the body responds better to its own supply. Notice what it does NOT do: it doesn't squeeze extra insulin out of the pancreas. This is the key to its safety. A drug that forces out more insulin (like a sulfonylurea) can drive glucose too low and cause a hypo; metformin merely dials down excess glucose production and improves sensitivity, so on its own it cannot crash the glucose below normal. That's why metformin is described as having no hypoglycaemia risk when used alone, and why it doesn't cause weight gain — two advantages that flow directly from its mechanism.
Side effects and the one serious danger
Metformin's common problem is the gut: nausea, a metallic taste, cramps and diarrhoea, especially when starting. These are usually manageable by starting at a low dose, increasing slowly, taking it with food, or using a slow-release form — and they often settle. Over the long term it can slightly reduce absorption of vitamin B12, worth checking on prolonged use. But the one serious danger to respect is rare: lactic acidosis — a dangerous build-up of acid in the blood. It almost only happens when metformin accumulates because the kidneys can't clear it, so the golden safety rule is about the kidneys: metformin must be reduced or stopped when kidney function is poor, and it is temporarily withheld in situations that can suddenly harm the kidneys — serious acute illness, dehydration, or around procedures using intravenous contrast dye. Respect the kidney rule and metformin is one of the safest drugs in medicine.
- Metformin is first-line for type 2 diabetes — cheap, effective, no weight gain.
- It reduces liver glucose output and improves insulin sensitivity — it doesn't secrete insulin.
- No hypoglycaemia when used alone — a direct result of not forcing out insulin.
- Common: GI upset and B12 lowering; start low, go slow, take with food.
- Rare but serious: lactic acidosis — hold/reduce with poor kidneys, acute illness, or IV contrast.
The cleanest way to remember why metformin never causes a hypo on its own is to contrast the two big diabetes strategies. Drugs that add insulin or force it out (insulin itself, sulfonylureas) can overshoot and drop glucose below normal — they push. Metformin doesn't push; it releases the brake on insulin sensitivity and turns down the liver's glucose tap. You can improve how the body handles glucose all you like, but if you're not force-feeding insulin, you can't drag the level below where the body wants it. That single idea — 'sensitisers don't cause hypos, secretagogues do' — sorts half the diabetes drugs into safe-alone versus watch-for-lows.
- Continuing metformin when kidney function drops sharply — lactic acidosis risk.
- Not holding it around IV contrast or serious acute illness/dehydration.
- Starting at full dose — causes avoidable GI upset; titrate up slowly with food.
- Blaming metformin for a hypo — alone it doesn't cause one; look for another cause/drug.
What is metformin's main mechanism for lowering blood glucose?
- Metformin is first-line for type 2: lowers liver glucose, improves insulin sensitivity.
- No hypoglycaemia alone and no weight gain — it doesn't force out insulin.
- Common: GI upset, B12 lowering. Start low, go slow, with food.
- Rare, serious: lactic acidosis — respect the kidney rule (hold with poor renal function/contrast).
- Katzung BG. Basic & Clinical Pharmacology — Pancreatic Hormones & Antidiabetic Drugs (biguanides).
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Oral antidiabetic agents.
- ADA — Standards of Care in Diabetes (pharmacologic approaches).
- Whalen K. Lippincott Illustrated Reviews: Pharmacology — Metformin.
